NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT05247957 · TERMINATED
Trial details
- NCT number
- NCT05247957
- Sponsor
- Hangzhou Cheetah Cell Therapeutics Co., Ltd
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2022-12-12
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.